Nursing Care Plans Ineffective Airway Clearance Nursing Diagnosis & Care Plans: Assessment & Interventions
When a patient can’t clear their own airway, oxygenation and ventilation start losing ground fast. When airway obstruction or retained secretions threaten oxygenation or ventilation, ineffective airway clearance becomes a high-priority nursing diagnosis — and one of the most common you’ll write in pulmonary, post-op, and ICU patients.
Let’s make this simple. This guide walks through the diagnosis the way it actually shows up on care plans and NCLEX-RN® questions — NANDA framing, assessment with rationales, SMART goals, interventions, and five worked sample care plans (pneumonia, COPD, post-op atelectasis, asthma, tracheostomy) you can adapt for any patient.
In this guide
- What is ineffective airway clearance?
- Pathophysiology of ineffective airway clearance
- Causes (Related to)
- Signs and symptoms (As evidenced by)
- Sample nursing diagnoses
- Goals and outcomes (SMART format)
- Nursing assessment with rationales
- Nursing interventions (with rationales)
- Sample care plans — 5 scenarios
- Escalation red flags (high-yield)
- Discharge and patient teaching
- Frequently asked questions
- Related care plans
- References
What is ineffective airway clearance?
Ineffective airway clearance is a NANDA-I nursing diagnosis defined as the inability to clear secretions or obstructions from the respiratory tract to maintain a clear airway.¹ It applies whenever excessive secretions, weak cough, airway obstruction, sedation, or an artificial airway interferes with the body’s normal clearance mechanisms.
A patent airway depends on three things: the structure of the conducting airways (nose, pharynx, larynx, trachea, bronchi, bronchioles), the mucociliary escalator (cilia constantly sweeping mucus upward toward the throat), and an effective cough reflex. When any of those fails, secretions accumulate and the cascade you assess for begins — V/Q mismatch, atelectasis, infection risk, hypoxemia, and eventually respiratory failure. For an anatomy and physiology refresher, see the NCBI Nursing Fundamentals chapter on respiratory assessment.²
Don’t confuse these three respiratory diagnoses: Ineffective airway clearance is about the airway (secretions, obstruction). Ineffective breathing pattern is about the mechanics (rate, depth, rhythm). Impaired gas exchange is about the alveolar-capillary interface (oxygenation or CO₂ removal). A single patient may meet criteria for all three at the same time — use each diagnosis only when the assessment data support it.¹
Pathophysiology of ineffective airway clearance
The airway has two main defenses against secretions and foreign material: the mucociliary escalator and the cough reflex. Cilia lining the conducting airways beat at about 1,000 strokes per minute, propelling a thin mucus layer (with trapped particles and pathogens) up toward the pharynx to be swallowed or coughed out.²
Ineffective airway clearance happens when one or more of these mechanisms overwhelm tissue capacity:
- Excessive mucus production — infection, allergic response, chronic inflammation
- Thickened secretions — dehydration, drying from supplemental oxygen, certain medications
- Impaired ciliary function — smoking (cilia paralyze within minutes of inhalation), anesthesia, repeated infections, ciliary dyskinesia
- Weak or absent cough — pain (post-op splinting), sedation, neuromuscular disease, decreased level of consciousness, oversedation
- Airway obstruction — foreign body, bronchospasm, edema (anaphylaxis), tumor, blood, vomitus
- Bypassed upper airway — endotracheal tube or tracheostomy (loses warming, humidification, and ciliary clearance from the upper airway)
Once secretions accumulate, V/Q mismatch develops — areas of lung where ventilation is blocked but perfusion continues. The blood leaving those areas isn’t oxygenated. SpO₂ drops, work of breathing increases, and the patient progresses toward respiratory failure if not corrected.
For exams, focus on this: when SpO₂ starts dropping in a patient with secretions, the first interventions are clear the airway (cough, suction, position) and oxygenate. Don’t reach for the oxygen mask and ignore the underlying clearance problem — you’ll mask the trend while the patient deteriorates.
Causes (Related to)
On your care plan, the phrase after “Related to” should name the specific cause for your patient, not the broad category.¹
Excessive or retained secretions
- Infection — pneumonia, bronchitis, sinusitis
- Chronic mucus production — COPD, cystic fibrosis, bronchiectasis
- Allergic response — asthma, allergic bronchopulmonary aspergillosis
- Post-operative pain causing splinted, shallow breathing
Impaired cough or swallow reflex
- Sedation, anesthesia, oversedation
- Decreased level of consciousness, stroke
- Neuromuscular disease — ALS, Parkinson’s, myasthenia gravis, Guillain-Barré
- Post-extubation weakness
- Cognitive impairment, dementia
Airway obstruction or bronchospasm
- Foreign body aspiration
- Tumor, mass, or external compression
- Edema — anaphylaxis, smoke inhalation, burns to the face or neck
- Bronchospasm — asthma exacerbation, COPD exacerbation, anaphylaxis
Artificial airway
- Endotracheal tube (bypasses upper-airway humidification and ciliary clearance)
- Tracheostomy
- Mechanical ventilation
Other contributors
- Smoking — paralyzes cilia and increases mucus production
- Exposure to air pollution or occupational irritants
- Dehydration — thickens secretions
- Decreased mobility — pooling of secretions in dependent lung regions
- Chronic corticosteroid use — increases infection risk
Signs and symptoms (As evidenced by)
A NANDA-I diagnostic statement is supported by defining characteristics. Use patient-reported (subjective) data when available, plus objective findings. For an alert patient, include both. For a sedated, unconscious, or intubated patient, objective findings alone are sufficient — inability to report does not negate the diagnosis.¹
Subjective data — what the patient reports
- Dyspnea, shortness of breath (“I can’t catch my breath”)
- Chest tightness or pressure
- Sensation of mucus stuck in the airway or throat
- Difficulty clearing secretions despite coughing
- Anxiety related to breathing
Objective data — what you observe
- Auscultation: rhonchi (low-pitched, snoring sounds — secretions in large airways), crackles (popping sounds that may reflect fluid, secretions, alveolar reopening, or interstitial changes depending on timing, pitch, and location), wheezes (high-pitched, expiratory — bronchospasm or narrowing), diminished or absent breath sounds
- Respiratory rate: tachypnea (> 20/min in adults) — or, late, bradypnea
- Respiratory effort: accessory muscle use, retractions, nasal flaring (especially pediatric), prolonged expiration
- Cough: weak, ineffective, productive with thick secretions, or absent when expected
- Secretions: quantity, color, consistency, odor, and change from baseline. Yellow, green, or purulent sputum may occur with airway inflammation or infection — but color alone does not distinguish viral from bacterial infection. Interpret with fever, WBC, imaging, culture, and clinical course. Rust-colored sputum is classically associated with pneumococcal pneumonia; pink frothy sputum suggests pulmonary edema; foul odor may suggest anaerobic infection.
- Cyanosis — central (lips, oral mucosa) or peripheral (nail beds); a late sign
- Tripod positioning or inability to lie flat
- Restlessness, agitation, or altered mental status — early hypoxia
- Pursed-lip breathing — characteristic of COPD
Measurable findings that support the diagnosis
- SpO₂ < 92% on room air (varies with patient baseline)
- ABG: PaO₂ below expected range for age, FiO₂, and clinical condition (mild hypoxemia 60–79 mmHg on room air; PaO₂ < 60 mmHg or falling PaO₂ despite supplemental oxygen is especially concerning — this is where the oxygen-hemoglobin dissociation curve drops sharply). Hypercapnia (PaCO₂ > 45 mmHg) if ventilation is also compromised.
- Elevated WBC if infection present
- Chest X-ray findings: consolidation, atelectasis, infiltrates
- Peak expiratory flow rate (PEFR) decreased in asthma exacerbation
Sample nursing diagnoses
Use this format on your care plan:
Ineffective airway clearance related to [specific cause] as evidenced by [subjective + objective findings].
Five worked examples covering the most common student-assigned scenarios:
- Pneumonia: Ineffective airway clearance related to retained pulmonary secretions in the setting of community-acquired pneumonia as evidenced by productive cough with thick yellow sputum, coarse rhonchi over the right lower lobe, dyspnea on exertion, SpO₂ 88% on room air, and elevated WBC.
- COPD exacerbation: Ineffective airway clearance related to excessive mucus production and impaired ciliary function in COPD as evidenced by chronic productive cough, prolonged expiratory phase, diminished breath sounds bilaterally, SpO₂ 89% on 2 L/min via nasal cannula, and audible wheezing.
- Post-operative atelectasis: Ineffective airway clearance related to shallow respirations and decreased mobility post-operatively as evidenced by diminished breath sounds at the lung bases, weak splinted cough secondary to incisional pain, decreased chest expansion, and SpO₂ 91% on room air.
- Asthma exacerbation: Ineffective airway clearance related to bronchospasm and airway inflammation as evidenced by audible expiratory wheezing, accessory muscle use, prolonged expiratory phase, peak expiratory flow rate 60% of predicted, and reported chest tightness.
- Tracheostomy / artificial airway: Ineffective airway clearance related to presence of tracheostomy tube and decreased mucociliary clearance as evidenced by visible secretions in the tube, audible rhonchi, SpO₂ 92% on 30% FiO₂, and inability to clear secretions independently.
Risk for ineffective airway clearance (when no actual problem yet)
For a risk diagnosis there’s no actual problem yet, so the format drops “as evidenced by” defining characteristics and uses “related to” with the patient’s risk factors only. If the patient already has an ineffective cough, diminished breath sounds, retained secretions, or low SpO₂, that supports the actual diagnosis — not the risk diagnosis.
Risk for ineffective airway clearance related to recent abdominal surgery, history of smoking, opioid analgesia and sedation, and decreased mobility.
Note: NANDA-I terminology for risk variants is updated periodically. Verify the exact label your program requires — some recent editions phrase this as “Risk for airway clearance impairment.”
Goals and outcomes (SMART format)
Strong nursing goals are Specific, Measurable, Attainable, Realistic, and Time-bound. Use a measurable change, a defined timeframe, and a patient-centered subject.
Short-term goals (within 1–2 hours or end of shift)
- Patient will demonstrate effective coughing technique and clear airway secretions by end of shift.
- Patient will maintain SpO₂ within the prescribed or condition-specific target range — typically 94–98% for most acute-care adults or 88–92% for COPD or chronic-hypercapnia risk — on prescribed oxygen by end of shift, per provider orders.
- Patient will demonstrate use of incentive spirometer 10 times per hour while awake.
- Patient will report decreased dyspnea after intervention (positioning, nebulizer, suctioning).
- Patient will exhibit clear or improving breath sounds on auscultation within 4 hours.
Long-term goals (within 24–72 hours or by discharge)
- Patient will maintain a patent airway with clear breath sounds throughout the shift.
- Patient will verbalize understanding of airway-clearance techniques and red-flag symptoms prior to discharge.
- Patient will demonstrate independent airway clearance using prescribed techniques (huff coughing, autogenic drainage, incentive spirometry) prior to discharge.
Function-based goals
Pair every intensity goal with a function goal:
- Patient will tolerate ambulation 50 feet without dyspnea.
- Patient will sleep ≥ 4 uninterrupted hours without respiratory distress.
- Patient will complete activities of daily living without using accessory muscles.
High-yield flag: the NCLEX-RN favors goals that are patient-centered (start with “Patient will…”) and measurable (uses a number, scale, or timeframe). If a goal can’t be evaluated as “met” or “not met,” rewrite it.
Nursing assessment with rationales
Assessment items with rationales
| Assess | Why we do it | What to document |
|---|---|---|
| Respiratory rate, depth, and effort | Earliest objective change in respiratory deterioration | Rate, regularity, use of accessory muscles, retractions |
| Auscultation — all lobes, anterior and posterior | Pinpoints location and type of airway problem | Specific lobe, character of sound (rhonchi/crackles/wheeze), pre- and post-intervention |
| SpO₂ trend and oxygen requirement | Quantifies hypoxemia and tracks response to interventions | Reading, FiO₂ or L/min delivery, position |
| Cough | Distinguishes effective from ineffective clearance | Productivity, strength, splinting, character |
| Sputum | Color and consistency indicate infection type and severity | Color, consistency, quantity, odor |
| Level of consciousness | Early hypoxia presents as restlessness or confusion before cyanosis | LOC, orientation, agitation |
| Skin color and capillary refill | Cyanosis is a late sign — circulation status helps interpret it | Central vs peripheral cyanosis, capillary refill seconds |
| Position the patient chooses | Tripod and refusal to lie flat are signs of severe respiratory distress | Self-positioning, response to repositioning |
| Vital signs trend | Tachycardia is an early compensation; bradycardia is a late and dangerous sign | HR, BP, RR, SpO₂ trend over time |
| Hydration status | Dehydration thickens secretions | Mucous membranes, urine output, skin turgor, recent intake |
| Smoking and exposure history | Identifies modifiable contributing factors | Pack-years, current use, occupational or environmental exposures |
| Pain control adequacy | Uncontrolled pain → splinted breathing → atelectasis | Pain rating, splinting behavior, response to analgesia |
| ABG when indicated | Directly assesses oxygenation and acid-base balance | pH, PaO₂, PaCO₂, HCO₃ — trend across draws |
Key diagnostic tests
- ABG — assesses oxygenation and acid-base balance directly. Rising PaCO₂ with falling pH signals decompensation.
- CBC — WBC trend for infection.
- Sputum culture and Gram stain — identifies the organism in suspected infection.
- Chest X-ray — identifies consolidation (pneumonia), atelectasis, effusion, pneumothorax.
- Peak expiratory flow rate (PEFR) — quantifies bronchospasm severity in asthma.
Nursing interventions for ineffective airway clearance (with rationales)
Airway-clearance techniques
| Intervention | Rationale |
|---|---|
| Encourage deep breathing and effective coughing (huff cough, controlled cough) | Mobilizes secretions for expectoration; huff coughing is more effective and less fatiguing than forceful coughing |
| Incentive spirometry (commonly 10 breaths per hour while awake, per facility protocol) | Promotes sustained maximal inspiration and lung expansion. Use as part of a postoperative pulmonary hygiene bundle with deep breathing, directed coughing, adequate pain control, repositioning, and early mobility — AARC notes incentive spirometry alone is not recommended as routine prophylaxis³ |
| Chest physiotherapy, postural drainage, oscillating PEP, or high-frequency chest wall oscillation per orders | Useful for selected patients with retained secretions, bronchiectasis, cystic fibrosis, neuromuscular weakness, artificial airways, or inability to clear secretions independently. Loosens secretions and promotes drainage. Not routine for every patient with pneumonia, COPD exacerbation, or postoperative atelectasis — early mobility, cough/deep breathing, bronchodilators, hydration, and treating the underlying cause are often more relevant first |
| Suctioning (oral, nasotracheal, or via artificial airway) per protocol | Removes secretions the patient cannot clear. Limit each pass to no more than 15 seconds, using the shortest effective duration; pre-oxygenate when appropriate; avoid routine saline instillation per AARC Artificial Airway Suctioning 2022 guidance³ |
| Autogenic drainage or active cycle of breathing technique (with respiratory therapy) | Controlled breathing patterns that mobilize secretions — useful for chronic conditions like CF and bronchiectasis |
| Oscillating PEP devices (Acapella, Flutter) or high-frequency chest wall oscillation vest per orders | Mechanical assistance for secretion mobilization in chronic-disease patients |
For suctioning and aerosol therapy specifics, the AARC Clinical Practice Guidelines are the authoritative reference.³
Positioning and mobility
| Intervention | Rationale |
|---|---|
| Elevate head of bed to 30–45° (or higher if tolerated) | Promotes lung expansion and reduces work of breathing |
| Reposition every 2 hours; encourage early mobility once safe | Prevents pooling of secretions and atelectasis in dependent regions |
| Allow tripod position or leaning forward over a bedside table when dyspneic | Recruits accessory muscles efficiently — common and helpful in COPD |
| Position for postural drainage of specific lobes per respiratory therapy | Uses gravity to drain secretions toward larger airways for expectoration |
Hydration and humidification
| Intervention | Rationale |
|---|---|
| Encourage oral fluids (1.5–2 L/day unless contraindicated by heart failure or fluid restriction) | Thins secretions and improves mucociliary clearance |
| Consider humidification for artificial airways, high-flow oxygen (typically > 4 L/min), thick secretions, or patient discomfort/dryness, per respiratory therapy and facility policy³ | Prevents drying of airway mucosa, which thickens secretions further |
Pharmacologic interventions
| Intervention | Rationale | Watch for |
|---|---|---|
| Short-acting bronchodilators (albuterol, ipratropium) per orders | Relaxes airway smooth muscle and reduces bronchospasm | Tachycardia, tremor (beta-2 agonists); dry mouth, urinary retention (anticholinergics) |
| Acetylcysteine (mucolytic) per orders | Decreases mucus viscosity by disrupting disulfide bonds in mucoprotein | Bronchospasm, airway irritation, distinctive sulfur odor |
| Hypertonic saline nebulization per orders | Draws water into airway surface liquid via osmotic effect, hydrating secretions | Bronchospasm — pretreat with bronchodilator per orders |
| Expectorants (guaifenesin) | Increases respiratory tract secretions, thinning mucus | Effect depends on adequate hydration |
| Inhaled corticosteroids per orders | Reduces airway inflammation in chronic disease | Oral thrush — rinse mouth after each use |
| Antibiotics per orders if bacterial infection is confirmed | Treats the underlying cause | Allergy, GI side effects; monitor culture and sensitivity |
| Oxygen therapy per orders, titrated to target SpO₂ | Corrects hypoxemia | In COPD with chronic CO₂ retention, target SpO₂ 88–92% per the GOLD Report⁴ — over-oxygenation can worsen hypercapnia |
Education and lifestyle
| Intervention | Rationale |
|---|---|
| Teach splinted coughing post-op (hold a pillow against the incision) | Reduces incisional pain that limits effective coughing |
| Demonstrate inhaler technique with a spacer; observe return demonstration | Most patients use inhalers incorrectly; correct technique roughly doubles drug delivery to the airways |
| Teach pursed-lip breathing for COPD | Slows expiration, reduces air trapping, and decreases work of breathing |
| Smoking cessation counseling | Smoking impairs ciliary clearance; cessation begins reversing impairment within months — refer to CDC tobacco cessation resources when appropriate⁵ |
Monitor for
- Worsening dyspnea or new respiratory distress
- Rising oxygen requirement or falling SpO₂
- Rising PaCO₂ (decompensation in COPD or neuromuscular disease)
- Decreased level of consciousness or new confusion
- New or worsening fever (infection)
- Hemoptysis — any blood-tinged sputum needs investigation
- Signs of impending respiratory failure: tripod positioning, paradoxical breathing, single-word dyspnea, silent chest in asthma (an ominous sign — wheezing has stopped because air is no longer moving)
Sample care plans (5 scenarios)
Scenario 1 — Pneumonia
Diagnostic statement: Ineffective airway clearance related to retained pulmonary secretions in the setting of community-acquired pneumonia as evidenced by productive cough with thick yellow sputum, coarse rhonchi over the right lower lobe, SpO₂ 88% on room air, and temperature 38.6 °C.
Short-term goal: Patient will demonstrate effective coughing, clear secretions, and maintain SpO₂ ≥ 92% on prescribed oxygen by end of shift.
Assessment: Respiratory rate and effort q2h; lung auscultation q4h; SpO₂ continuous; sputum (color, consistency, quantity); temperature; ABG when indicated; CBC and WBC trend; chest X-ray review; hydration status.
Interventions: Administer prescribed antibiotics and monitor response; encourage oral fluids (unless contraindicated) to thin secretions; provide humidified oxygen titrated to SpO₂ ≥ 92%; teach huff coughing and incentive spirometry; reposition q2h; elevate head of bed to 30–45°; provide chest physiotherapy if ordered; obtain sputum culture before antibiotics when feasible.
Evaluation: Breath sounds improving, SpO₂ at goal, sputum decreasing in volume, fever trending down, patient demonstrating effective cough.
Documentation tip — FDAR charting (used in many Filipino nursing programs): Focus: Ineffective airway clearance. Data: Productive cough with thick yellow sputum, coarse rhonchi RLL, SpO₂ 88% on RA, temp 38.6°C. Action: Administered antibiotics as ordered, started humidified O₂ at 2 L NC, taught huff cough and IS, elevated HOB to 45°. Response: SpO₂ rose to 94% within 30 minutes, patient cleared moderate amount of thick yellow sputum, reports decreased dyspnea.
Scenario 2 — COPD exacerbation
Diagnostic statement: Ineffective airway clearance related to excessive mucus production and impaired ciliary function in COPD as evidenced by chronic productive cough, prolonged expiratory phase, diminished breath sounds bilaterally, SpO₂ 89% on 2 L/min via nasal cannula, and audible wheezing.
Short-term goal: Patient will demonstrate use of pursed-lip breathing, achieve SpO₂ 88–92% on prescribed oxygen, and report decreased work of breathing by end of shift.
Assessment: Respiratory rate and effort; lung auscultation; SpO₂ trend (target 88–92% per GOLD guidance for chronic CO₂ retention)⁴; ABG when indicated (rising PaCO₂ + falling pH = decompensation); accessory muscle use; sputum; hydration; level of consciousness (CO₂ narcosis causes confusion and somnolence).
Interventions: Administer scheduled and PRN bronchodilators (albuterol, ipratropium) per orders; nebulized treatments as ordered; titrate oxygen to target SpO₂ 88–92% — do not over-oxygenate; teach pursed-lip breathing and energy-conservation techniques; elevate head of bed; provide humidified oxygen if secretions are thick; smoking-cessation counseling; consider BiPAP per provider order if decompensating.
Evaluation: Patient using pursed-lip breathing, SpO₂ in target range, work of breathing decreased, no signs of CO₂ narcosis.
Scenario 3 — Post-operative atelectasis
Diagnostic statement: Ineffective airway clearance related to shallow respirations and decreased mobility post-operatively (open abdominal surgery, post-op day 1) as evidenced by diminished breath sounds at the lung bases, weak splinted cough secondary to incisional pain, and SpO₂ 91% on room air.
Short-term goal: Patient will perform incentive spirometry 10 times per hour while awake, splint and cough effectively, and ambulate to the door with assistance by end of shift.
Assessment: Lung auscultation q4h (bases especially); SpO₂; pain rating and response to analgesia; incision site; incentive spirometer volumes trend; mobility tolerance; bowel function (ileus delays mobility).
Interventions: Provide multimodal analgesia (acetaminophen scheduled + PRN opioid) to enable splinted coughing — uncontrolled pain is the #1 cause of post-op atelectasis; teach and reinforce splinted coughing with a pillow over the incision; incentive spirometry 10 breaths q1h while awake; elevate head of bed; assist with ambulation early (post-op day 1 when safe); reposition q2h.
Evaluation: Breath sounds clearing at bases, SpO₂ ≥ 95% on room air, patient ambulating, pain controlled enough for effective coughing.
Scenario 4 — Asthma exacerbation
Diagnostic statement: Ineffective airway clearance related to bronchospasm and airway inflammation as evidenced by audible expiratory wheezing, accessory muscle use, prolonged expiratory phase, peak expiratory flow rate 60% of predicted, and reported chest tightness.
Short-term goal: Patient will report decreased dyspnea, PEFR improving to ≥ 80% of personal best, and SpO₂ ≥ 95% on room air within 1–2 hours.
Assessment: Respiratory rate and effort; auscultation (wheezing — paradoxically a “silent chest” with no wheezing in severe attack signals impending failure); SpO₂; PEFR (compare to personal best); accessory muscle use; ability to speak in sentences vs single words (single-word dyspnea = severe); peak expiratory flow rate trend.
Interventions: Administer short-acting bronchodilator (albuterol) per orders — repeated doses or continuous nebulization if severe; systemic corticosteroids per orders for moderate to severe exacerbation per the GINA Strategy Report⁶; oxygen titrated for hypoxemia to the current asthma guideline or facility target (typically 93–95% per GINA 2026⁶), avoiding unnecessary hyperoxia — unlike COPD with chronic CO₂ retention, asthma does not usually require a lower 88–92% target, but rising PaCO₂, “normalizing” PaCO₂ in a tiring patient, altered mental status, exhaustion, or a silent chest signals impending ventilatory failure and requires urgent escalation; ipratropium added per orders if severe; observe inhaler technique with spacer when stable; review trigger avoidance; avoid nonselective beta-blockers during active bronchospasm and notify the provider if a beta-blocker is ordered — cardioselective beta-blockers may be used cautiously for strong cardiovascular indications under prescriber guidance; be prepared to escalate for impending respiratory failure.
Evaluation: Wheezing decreased or resolved, PEFR improved, patient speaking in full sentences, no accessory muscle use.
Scenario 5 — Tracheostomy / artificial airway
Diagnostic statement: Ineffective airway clearance related to presence of tracheostomy tube and decreased mucociliary clearance as evidenced by visible secretions in the tube, audible rhonchi, SpO₂ 92% on 30% FiO₂ via trach collar, and inability to clear secretions independently.
Short-term goal: Patient will maintain a patent tracheostomy with clear secretions and SpO₂ ≥ 94% on prescribed FiO₂ throughout the shift.
Assessment: Tracheostomy site and stoma condition; secretion amount, color, consistency; SpO₂ and FiO₂ requirement; auscultation; cuff pressure (if cuffed tube) — maintain 20–25 cmH₂O per current guidance; ability to communicate; risk of accidental decannulation.
Interventions: Suction the tracheostomy per AARC guidance — only when clinically indicated, not on a fixed schedule;³ pre-oxygenate before suctioning; limit each pass to 10–15 seconds; use sterile technique for inner-cannula care per facility protocol; provide humidified oxygen via trach collar or HME (heat and moisture exchanger); maintain head of bed elevation; ensure backup trach kit (same size and one size smaller, obturator, suction supplies) at the bedside at all times; communication board if patient cannot speak.
Evaluation: Trach patent, secretions decreasing, SpO₂ at goal, no signs of infection at stoma, patient communicating needs effectively.
Escalation red flags (high-yield)
| Situation | Escalate for |
|---|---|
| Any patient | Falling SpO₂ despite increasing oxygen, decreased LOC, new confusion, single-word dyspnea, paradoxical breathing, tripod positioning |
| Pneumonia | Persistent fever > 48 h on antibiotics, expanding consolidation, hemoptysis, signs of sepsis |
| COPD | Rising PaCO₂ with falling pH, somnolence (CO₂ narcosis), tripod position despite treatment, single-word dyspnea |
| Asthma | “Silent chest” (no wheezing in a previously wheezing patient — air no longer moving), falling PEFR despite treatment, exhaustion, decreased mental status |
| Post-op | Sudden chest pain or dyspnea (rule out PE), hypoxia not responding to incentive spirometry, fever post-op day 3+, abnormal incision findings |
| Tracheostomy | Accidental decannulation, tube obstruction, bleeding from stoma, subcutaneous emphysema, signs of sepsis |
Discharge and patient teaching
| Teaching point | What the nurse explains |
|---|---|
| Inhaler and nebulizer technique | Use a spacer with metered-dose inhalers; rinse mouth after inhaled corticosteroids; demonstrate return technique before discharge |
| Smoking cessation | Smoking paralyzes cilia and worsens every form of ineffective airway clearance; provide cessation resources |
| Hydration | 1.5–2 L/day (unless contraindicated) keeps secretions thin and easier to clear |
| Recognize red flags | Increasing shortness of breath, fever, change in sputum color/quantity, blood in sputum, increased need for rescue inhaler, decreasing energy |
| When to seek emergency care | Severe shortness of breath, inability to speak in sentences, blue lips or fingernails, chest pain, confusion |
| Home oxygen safety (if applicable) | No smoking near oxygen, secure tanks, check tubing daily, target SpO₂ per provider |
| Action plan (asthma) | Use the green-yellow-red zone plan; reach for the rescue inhaler at first symptoms; call provider when in the yellow zone, ED when in the red zone — see GINA⁶ for current action plans |
| Vaccinations | Annual influenza vaccine and pneumococcal vaccines per CDC schedules⁵ for at-risk respiratory patients |
| Energy conservation | Pursed-lip breathing, planned rest, pacing activity to avoid dyspnea spikes |
Frequently asked questions
What is ineffective airway clearance?
Ineffective airway clearance is a NANDA-I nursing diagnosis describing the inability to clear secretions or obstructions from the respiratory tract to maintain a patent airway.¹ It applies whenever excessive secretions, weak cough, airway obstruction, or an artificial airway interferes with normal clearance.
What does ineffective airway clearance mean on a care plan?
It means the patient cannot keep their own airway clear, putting them at risk for hypoxemia, atelectasis, and respiratory failure. The nursing care plan focuses on clearing secretions, supporting an effective cough, maintaining oxygenation, and treating the underlying cause.
What are the risk factors for ineffective airway clearance?
Common risk factors include smoking, COPD, asthma, infection (pneumonia, bronchitis), neuromuscular disease, sedation or decreased consciousness, recent surgery (especially abdominal or thoracic), tracheostomy or endotracheal tube, dehydration, and decreased mobility.
What is the difference between ineffective airway clearance, ineffective breathing pattern, and impaired gas exchange?
Three respiratory diagnoses students often confuse. Ineffective airway clearance is about the airway — secretions or obstruction blocking flow. Ineffective breathing pattern is about the mechanics — rate, depth, rhythm. Impaired gas exchange is about the alveolar-capillary interface — oxygenation or CO₂ removal. A single patient can have all three at once.¹
How do you write a SMART goal for ineffective airway clearance?
Use a measurable change and a timeframe. Instead of “Patient will breathe better,” write “Patient will demonstrate effective coughing and clear airway secretions, with SpO₂ in the prescribed target range (typically 94–98% for most acute-care adults or 88–92% for COPD with chronic CO₂ retention), by end of shift.” Pair every intensity goal with a function goal — pain controlled enough to cough, ambulate, sleep, or participate in therapy.
What does “as evidenced by” mean for ineffective airway clearance?
The “as evidenced by” portion of the diagnostic statement lists the specific subjective and objective findings that prove the diagnosis applies to this patient — typically the abnormal breath sounds, cough characteristics, SpO₂ value, respiratory rate and effort, and any secretions described. For an alert patient include both subjective and objective; for a sedated or intubated patient, objective findings alone are sufficient.
Practice question (chronic bronchitis)
Which recommendation is appropriate for the nurse to provide when a client reports sleep disturbances due to ineffective airway clearance related to chronic bronchitis? (Select all that apply.)
- Drink at least 2 to 3 liters of oral fluids daily.
- Use a cool mist humidifier at bedtime.
- Practice breathing slowly through pursed lips throughout the night.
- Take guaifenesin 400 mg orally every 4 hours.
- Use chest physiotherapy as needed.
- Use a tripod breathing position throughout the night.
Answers: 1, 2, 4, and 5. Adequate fluids (typically 1.5–2 L/day, unless contraindicated by heart failure, kidney disease, fluid restriction, or aspiration risk) thin the mucus clogging the airway. A cool-mist humidifier increases room humidity, helping thin secretions. Guaifenesin is an OTC expectorant that loosens secretions — use as prescribed or per label instructions. Chest physiotherapy is appropriate for selected patients with retained secretions (e.g., chronic bronchitis, bronchiectasis) and uses percussion, vibration, deep breathing, and coughing. Pursed-lip breathing is helpful intermittently but isn’t a continuous sleep recommendation, and tripod positioning is for active dyspnea, not routine sleep.
Related care plans
- Asthma Nursing Care Plan
- COPD Nursing Care Plan
- Pneumonia Nursing Care Plan
- Impaired Gas Exchange Nursing Care Plan
- Ineffective Breathing Pattern Nursing Care Plan
- Chest Pain Nursing Care Plan
- Acute Pain Nursing Care Plan
- Risk of Infection Nursing Care Plan
Ineffective airway clearance care plans look intimidating until you realize they follow a clear skeleton — NANDA statement, assessment, intervention, evaluation. Lock the skeleton in once and every scenario (pneumonia, COPD, post-op, asthma, trach) becomes a fill-in-the-blank. You’ve got this.
Ready to test what you just learned? Try a few respiratory and oxygenation practice questions in NCLEX format and lock in the priority-action patterns before test day.
References
- Herdman TH, Kamitsuru S, Lopes CT, eds. NANDA International Nursing Diagnoses: Definitions and Classification, 2024–2026. 13th ed. Thieme; 2024. Publisher product page
- Ernstmeyer K, Christman E, eds. Nursing Fundamentals. Chippewa Valley Technical College; 2021. Respiratory chapter. NCBI Bookshelf
- American Association for Respiratory Care (AARC). Clinical Practice Guidelines. Specific guidelines referenced: Artificial Airway Suctioning (2022), Management of Adult Patients with Oxygen in the Acute Care Setting (2022), Incentive Spirometry (2011, noting IS alone is not recommended as routine prophylaxis). aarc.org clinical practice guidelines
- Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for Prevention, Diagnosis and Management of COPD — 2026 Report. goldcopd.org
- Centers for Disease Control and Prevention (CDC). Tobacco cessation resources and current CDC/ACIP immunization schedule. cdc.gov/tobacco · cdc.gov/vaccines/schedules
- Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention — 2026 Update. ginasthma.org
